20cm速递｜科创创业ETF（588360）涨超2.0%，医保数据开放或加速创新药研发

Group 1 - The National Smart Medical Insurance Competition reflects the government's supportive attitude towards the development of innovative drugs, with open medical insurance data empowering drug research and development [1] - Medical insurance data covers a large population and has rich dimensions, providing substantial real-world data support for innovative drug development, helping teams accurately target clinical needs and determine research directions, thereby improving research efficiency [1] - The competition promotes cross-industry resource integration among pharmaceutical companies, technology firms, and research institutions, with big data analysis and artificial intelligence technologies from tech companies combining with drug research to create new research models and accelerate the transition of innovative drugs from the lab to clinical application [1] Group 2 - Long-term, the deepening application of medical insurance data in innovative drug development is expected to enhance both the quantity and quality of innovative drugs, indicating high growth potential and investment value in this sector [1] - The Science and Technology Innovation and Entrepreneurship ETF (588360) tracks the Science and Technology Innovation 50 Index (931643), which can fluctuate by up to 20% in a single day, reflecting the overall performance of listed companies in high-tech industries such as new-generation information technology, biomedicine, and high-end equipment manufacturing [1] - Investors without stock accounts can consider the Guotai Zhongzheng Science and Technology Innovation and Entrepreneurship 50 ETF Initiated Link C (013307) and Link A (013306) [1]